ANRO — ALTO NEUROSCIENCE INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 122 家机构在其最新 13F 申报中持有 ANRO(ALTO NEUROSCIENCE INC),合计申报市值 $797.88M,对应 30.60M 股。按股数计算较上季度增持 7.4%(+1.96M 股),申报市值环比上升 26.4%。持仓集中度较高:前五大持有人占申报市值的 38.9%,前十大的集中度为 58.2%。
与上一季度相比,29 家新建仓位、38 家加仓、29 家减仓、22 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
ALTO NEUROSCIENCE INC(ANRO)的主要机构持有人包括 Alpha Wave Global, LP、Commodore Capital LP、BlackRock Inc,按 13F 申报市值在本页 220 家持有人中排名居前。
ANRO 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 88 | 18.66M | $474.33M | +26.7% |
| Q2 2026 | 122 | 30.60M | $797.88M | +7.4% |
| Q1 2026 | 115 | 27.89M | $618.05M | +4.3% |
| Q4 2025 | 102 | 25.15M | $447.20M | +23.5% |
| Q3 2025 | 78 | 17.04M | $68.28M | -3.1% |
| Q2 2025 | 83 | 17.74M | $38.91M | -13.3% |
| Q1 2025 | 87 | 20.58M | $44.33M | -8.4% |
| Q4 2024 | 79 | 22.36M | $91.00M | +5.6% |
表内 8 个季度中,机构持股合计减少 17%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(+23.5%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.71M | $94.66M | 2.30% | 持有 | |
| 2.73M | $69.60M | 0.00% | 增持 | |
| 1.69M | $43.16M | 0.00% | 增持 | |
| 1.68M | $42.80M | 6.80% | 增持 | |
| 1.36M | $34.72M | 3.94% | 增持 | |
| 946.04K | $24.15M | 0.00% | 增持 | |
| 993.49K | $23.15M | 0.01% | 减持 | |
| 859.31K | $21.94M | 0.04% | 增持 | |
| 832.26K | $21.25M | 0.00% | 增持 | |
| 643.34K | $16.42M | 0.77% | 减持 | |
| 425.00K | $10.85M | 0.15% | 新进 | |
| 353.69K | $9.03M | 0.00% | 增持 | |
| 280.04K | $7.15M | 0.00% | 增持 | |
| 271.99K | $6.94M | 0.00% | 增持 | |
| 261.02K | $6.66M | 0.00% | 增持 | |
| 150.75K | $3.85M | 0.00% | 增持 | |
| 92.80K | $2.37M | 0.00% | 增持 | |
| 87.10K | $2.32M | 0.00% | 增持 | |
| 81.62K | $2.08M | 0.26% | 增持 | |
| 79.45K | $2.03M | 0.00% | 减持 | |
| 78.29K | $2.00M | 0.00% | 增持 | |
| 76.46K | $1.95M | 0.01% | 增持 | |
| 70.00K | $1.79M | 0.17% | 减持 | |
| 69.91K | $1.78M | 0.00% | 增持 | |
| 63.99K | $1.63M | 0.28% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.71M | $83.35M | 10.54% | 持有 | |
| 2.72M | $61.22M | 3.54% | 增持 | |
| 2.06M | $46.40M | 1.30% | 减持 | |
| 2.01M | $45.18M | 0.95% | 增持 | |
| 1.33M | $29.12M | 7.00% | 增持 | |
| 1.21M | $27.13M | 0.00% | 新进 | |
| 1.10M | $24.77M | 0.01% | 减持 | |
| 1.04M | $23.28M | 1.94% | 持有 | |
| 912.00K | $20.50M | 0.41% | 减持 | |
| 821.98K | $18.48M | 0.01% | 增持 | |
| 821.98K | $18.48M | 0.03% | 增持 | |
| 667.78K | $15.01M | 30.27% | 持有 | |
| 666.19K | $14.98M | 0.00% | 增持 | |
| 515.00K | $11.58M | 1.41% | 持有 | |
| 503.09K | $11.31M | 0.04% | 减持 | |
| 500.00K | $11.24M | 0.60% | 新进 | |
| 500.00K | $11.24M | 0.64% | 增持 | |
| 500.00K | $11.24M | 0.42% | 新进 | |
| 486.73K | $10.94M | 0.08% | 增持 | |
| 473.40K | $10.64M | 0.00% | 持有 | |
| 386.43K | $8.69M | 0.01% | 新进 | |
| 385.00K | $8.65M | 0.01% | 新进 | |
| 371.21K | $8.35M | 0.00% | 增持 | |
| 292.90K | $6.59M | 0.00% | 增持 | |
| 227.10K | $5.11M | 0.01% | 减持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.71M | $66.00M | 8.09% | 持有 | |
| 2.48M | $44.23M | 1.50% | 增持 | |
| 1.82M | $32.45M | 2.16% | 新进 | |
| 1.78M | $31.76M | 0.60% | 增持 | |
| 1.61M | $28.60M | 0.11% | 增持 | |
| 1.54M | $27.34M | 0.34% | 减持 | |
| 1.37M | $24.31M | 0.00% | 增持 | |
| 1.12M | $19.93M | 0.01% | 减持 | |
| 1.04M | $18.43M | 1.19% | 新进 | |
| 667.78K | $11.89M | 23.50% | 持有 | |
| 629.99K | $11.21M | 0.01% | 增持 | |
| 629.99K | $11.21M | 0.02% | 增持 | |
| 607.87K | $10.82M | 0.00% | 增持 | |
| 515.00K | $9.17M | 1.06% | 增持 | |
| 477.10K | $8.49M | 0.04% | 持有 | |
| 474.37K | $8.44M | 0.00% | 增持 | |
| 375.00K | $6.67M | 0.35% | 减持 | |
| 336.76K | $5.99M | 0.04% | 新进 | |
| 287.44K | $5.12M | 0.00% | 增持 | |
| 253.99K | $4.52M | 3.85% | 减持 | |
| 225.00K | $4.00M | 0.39% | 减持 | |
| 222.84K | $3.97M | 1.31% | 新进 | |
| 193.11K | $3.44M | 0.01% | 减持 | |
| 160.10K | $2.85M | 0.01% | 增持 | |
| 156.32K | $2.78M | 0.00% | 增持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.71M | $14.91M | 1.51% | 持有 | |
| 1.64M | $6.58M | 0.10% | 增持 | |
| 1.33M | $5.36M | 0.02% | 持有 | |
| 1.16M | $4.67M | 0.00% | 持有 | |
| 1.11M | $4.44M | 0.00% | 增持 | |
| 950.00K | $3.82M | 0.17% | 持有 | |
| 825.23K | $3.32M | 0.01% | 减持 | |
| 667.78K | $2.68M | 3.95% | 持有 | |
| 477.10K | $1.92M | 0.01% | 持有 | |
| 461.29K | $1.85M | 0.00% | 持有 | |
| 400.00K | $1.61M | 0.14% | 持有 | |
| 367.88K | $1.48M | 0.00% | 减持 | |
| 315.76K | $1.27M | 0.00% | 增持 | |
| 315.76K | $1.27M | 0.00% | 增持 | |
| 281.96K | $1.14M | 1.02% | 增持 | |
| 280.48K | $1.13M | 0.11% | 持有 | |
| 250.00K | $1.00M | 0.03% | 持有 | |
| 237.90K | $956.86K | 0.00% | 增持 | |
| 195.15K | $784.48K | 0.18% | 持有 | |
| 155.68K | $625.82K | 0.00% | 增持 | |
| 155.37K | $624.57K | 0.02% | 新进 | |
| 149.90K | $602.60K | 0.00% | 增持 | |
| 139.03K | $558.90K | 0.00% | 减持 | |
| 122.00K | $490.45K | 0.00% | 减持 | |
| 116.58K | $468.65K | 0.00% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.71M | $8.16M | 0.88% | 持有 | |
| 1.62M | $3.57M | 0.06% | 增持 | |
| 1.33M | $2.93M | 0.01% | 增持 | |
| 1.16M | $2.56M | 0.00% | 持有 | |
| 1.08M | $2.39M | 0.00% | 减持 | |
| 950.00K | $2.09M | 0.11% | 增持 | |
| 937.41K | $2.06M | 0.00% | 增持 | |
| 667.78K | $1.47M | 3.83% | 持有 | |
| 561.85K | $1.24M | 0.00% | 减持 | |
| 477.10K | $1.05M | 0.00% | 持有 | |
| 463.34K | $1.02M | 0.00% | 减持 | |
| 428.22K | $942.08K | 0.00% | 减持 | |
| 400.00K | $880.00K | 0.08% | 持有 | |
| 302.86K | $666.30K | 0.00% | 增持 | |
| 302.86K | $666.30K | 0.00% | 增持 | |
| 280.48K | $617.06K | 0.07% | 减持 | |
| 278.86K | $613.49K | 0.61% | 新进 | |
| 250.00K | $550.00K | 0.01% | 持有 | |
| 229.72K | $505.64K | 0.00% | 减持 | |
| 195.15K | $429.32K | 0.11% | 减持 | |
| 166.09K | $365.39K | 0.00% | 增持 | |
| 126.85K | $279.08K | 0.00% | 减持 | |
| 115.26K | $253.58K | 0.00% | 减持 | |
| 115.26K | $253.58K | 0.00% | 减持 | |
| 110.00K | $242.00K | 0.08% | 减持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 678.20K 股 · $17.90M
- Parkman Healthcare Partners LLC 429.04K 股 · $11.32M
- Schonfeld Strategic Advisors LLC 257.63K 股 · $6.80M
- VANGUARD PORTFOLIO MANAGEMENT LLC 181.10K 股 · $4.78M
- Sixth Street Partners Management Company, L.P. 80.58K 股 · $2.13M
- BNY Mellon 76.33K 股 · $2.01M
- Nuveen, LLC 62.34K 股 · $1.65M
- RHUMBLINE ADVISERS 31.64K 股 · $834.87K
- Deutsche Bank AG 26.05K 股 · $687.49K
- ALLIANCEBERNSTEIN L.P. 27.30K 股 · $613.70K
- MetLife Investment Management, LLC 15.64K 股 · $412.85K
- Virtus Investment Advisers, LLC 15.24K 股 · $402.16K
完全清仓(较上季)
- JENNISON ASSOCIATES LLC 卖出 386.43K 股 · $8.69M
- Qube Research & Technologies Ltd 卖出 209.27K 股 · $4.70M
- STATE STREET CORP 卖出 199.50K 股 · $4.48M
- Almitas Capital LLC 卖出 78.52K 股 · $1.77M
- D. E. Shaw & Co 卖出 45.34K 股 · $1.02M
- D. E. Shaw & Co., Inc. 卖出 45.34K 股 · $1.02M
- Hudson Bay Capital Management LP 卖出 43.76K 股 · $983.77K
- 683 Capital Management, LLC 卖出 40.00K 股 · $899.20K
- Brevan Howard Capital Management LP 卖出 38.78K 股 · $871.82K
- Balyasny Asset Management 卖出 32.11K 股 · $721.86K
- Y-Intercept (Hong Kong) Ltd 卖出 23.95K 股 · $538.28K
- LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 卖出 18.08K 股 · $406.50K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpha Wave Global, LP | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M |
| BlackRock Inc | 2.73M | 2.12M | 666.19K | 607.87K | 367.88K | 561.85K | 1.46M | 1.48M | 1.45M | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.69M | 1.39M | 1.21M | — | — | — | — | — | — | — | — |
| Spruce Street Capital LP | 1.68M | 1.35M | 1.33M | 222.84K | — | — | — | — | — | — | — |
| Vivo Capital, LLC | 1.36M | 1.21M | 1.04M | 1.04M | — | — | — | — | — | — | — |
| STATE STREET CORP | 946.04K | — | 199.50K | 130.66K | 103.19K | 104.73K | 338.72K | 339.71K | 236.86K | 105.87K | 25.40K |
| Franklin Resources | 993.49K | 1.01M | 1.10M | 1.12M | 1.16M | 1.16M | 1.16M | 1.16M | 1.22M | 625.04K | 625.01K |
| Marshall Wace | 859.31K | 225.50K | 176.35K | 193.11K | 825.23K | 937.41K | 852.99K | 837.37K | — | — | 21.29K |
| Geode Capital Management | 832.26K | 678.20K | 292.90K | 287.44K | 237.90K | 229.72K | 486.86K | 472.66K | 469.99K | 188.97K | 86.14K |
| Affinity Asset Advisors, LLC | 643.34K | 850.00K | 500.00K | — | — | — | — | — | — | — | — |
| EVENTIDE ASSET MANAGEMENT, LLC | 425.00K | — | — | — | — | — | — | — | — | — | — |
| Invesco Ltd | 353.69K | 14.26K | — | — | — | — | 31.03K | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 280.04K | 181.10K | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 271.99K | 211.26K | 165.27K | — | — | — | — | — | — | — | — |
| Morgan Stanley | 261.02K | 74.94K | 68.65K | 65.58K | 61.04K | 64.63K | 46.81K | 202.64K | 76.16K | 26.32K | 13.29K |
| Fidelity Management & Research (FMR) | 150.75K | 6.33K | 6.31K | 6.37K | 7.68K | 8.30K | 1.27M | 1.27M | 2.36M | 2.33M | 2.35M |
| BNY Mellon | 92.80K | 76.33K | — | — | — | — | 49.55K | 52.27K | 45.46K | 23.56K | — |
| TD ASSET MANAGEMENT INC | 87.10K | 43.80K | 43.80K | — | — | — | — | 110.79K | 76.99K | 86.79K | — |
| AdvisorShares Investments LLC | 81.62K | 70.75K | 41.02K | 44.08K | — | — | — | — | — | — | — |
| STIFEL FINANCIAL CORP | 79.45K | 85.48K | 86.33K | 87.16K | 122.00K | 126.85K | 130.14K | 128.70K | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold ANRO?
As of 2026-Q2, 122 institutional funds reported holding ANRO (ALTO NEUROSCIENCE INC) in SEC 13F filings, with a combined reported value of $797.88M.
How many shares of ANRO do institutions own?
13F filers reported 30.60M shares of ANRO, worth $797.88M in aggregate at the end of 2026-Q2.
Is institutional ownership of ANRO rising or falling?
Share counts moved +7.4% versus the prior quarter — accumulation.
Who are the top institutional holders of ANRO?
The largest 13F holders are Alpha Wave Global, LP, Commodore Capital LP, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, Spruce Street Capital LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ALTO NEUROSCIENCE INC?
The major shareholders of ALTO NEUROSCIENCE INC (ANRO) by reported 13F value are Alpha Wave Global, LP, Commodore Capital LP, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, Spruce Street Capital LP, among 220 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.